Literature DB >> 20502257

Reported outcome factors for pulmonary resection in metastatic colorectal cancer.

Joachim Pfannschmidt1, Hans Hoffmann, Hendrick Dienemann.   

Abstract

Pulmonary resection of metastatic colorectal cancer is widely practiced in surgical oncology. However, only a highly selected subset of patients is eligible for resection, and the average recurrence rate is still high. We reviewed the recent literature on pulmonary metastasectomy for colorectal cancer and tried to address the issue of patient selection based on prognostic parameters associated with long-term survival. No randomized phase III trials are available, and data for this review were retrieved only from retrospective studies. We excluded papers reporting on patients earlier than 1990. In summary, there is a substantial body of evidence demonstrating that resection of pulmonary metastases can be performed safely and with a low mortality rate. For a subset of highly selected patients, the overall results of a 5-year actuarial survival rate after complete resection ranged between 40 and 68%. These outcomes exceed those normally associated with metastatic colorectal cancer. It is this perception that has encouraged surgeons and caused the practice to grow.

Entities:  

Mesh:

Year:  2010        PMID: 20502257     DOI: 10.1097/JTO.0b013e3181dca330

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  41 in total

Review 1.  History and present status of pulmonary metastasectomy in colorectal cancer.

Authors:  Tom Treasure; Mišel Milošević; Francesca Fiorentino; Joachim Pfannschmidt
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 2.  Contemporary surgical options for metastatic colorectal cancer.

Authors:  Zhifei Sun; Julie M Thacker
Journal:  Curr Oncol Rep       Date:  2015-04       Impact factor: 5.075

3.  Morbidity, mortality, and survival in elderly patients undergoing pulmonary metastasectomy for colorectal cancer.

Authors:  S Sponholz; Moritz Schirren; Selma Oguzhan; Joachim Schirren
Journal:  Int J Colorectal Dis       Date:  2018-07-28       Impact factor: 2.571

4.  Microwave Ablation in the Management of Colorectal Cancer Pulmonary Metastases.

Authors:  I Kurilova; A Gonzalez-Aguirre; R G Beets-Tan; J Erinjeri; E N Petre; M Gonen; M Bains; N E Kemeny; S B Solomon; C T Sofocleous
Journal:  Cardiovasc Intervent Radiol       Date:  2018-05-29       Impact factor: 2.740

5.  Impact of cyclooxygenase-2 and prostaglandin-E2 expression on clinical outcome after pulmonary metastasectomy.

Authors:  Christian Lang; Emilie Hrdliczka; Thomas Schweiger; Olaf Glueck; Gerrit Lewik; Stefan Schwarz; Alberto Benazzo; György Lang; Walter Klepetko; Konrad Hoetzenecker
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

6.  In reply.

Authors:  Marco Tampellini; Francesco Ardissone; Giorgio Vittorio Scagliotti
Journal:  Oncologist       Date:  2013-04-26

7.  Surgery of colorectal cancer lung metastases: analysis of survival, recurrence and re-surgery.

Authors:  Francesco Guerrera; Claudio Mossetti; Manuela Ceccarelli; Maria Cristina Bruna; Giulia Bora; Stefania Olivetti; Paolo Olivo Lausi; Paolo Solidoro; Giovannino Ciccone; Enrico Ruffini; Alberto Oliaro; Pier Luigi Filosso
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

8.  The impact of primary tumor location on prognosis after colorectal lung metastasectomy.

Authors:  Stefan Sponholz; Selma Oguzhan; Mesut Mese; Moritz Schirren; Andreas Kirschbaum; Joachim Schirren
Journal:  Int J Colorectal Dis       Date:  2021-03-12       Impact factor: 2.571

Review 9.  Surgical intervention for pulmonary metastases.

Authors:  Joachim Pfannschmidt; Gerlinde Egerer; Marc Bischof; Michael Thomas; Hendrik Dienemann
Journal:  Dtsch Arztebl Int       Date:  2012-10-05       Impact factor: 5.594

10.  Factors affecting the outcome of a pulmonary resection for metastatic colorectal cancer: efficacy and pitfalls.

Authors:  Ik Yong Kim
Journal:  J Korean Soc Coloproctol       Date:  2010-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.